Nac (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac, is a mucolytic presented as a pharmaceutical‑grade powder for oral, buccal, and cutaneous use. It reduces the viscosity of respiratory secretions and is employed in the management of conditions with thick mucus.

GNH USA supplies Nac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and offers reliable global distribution to meet the needs of healthcare providers.

Acetylcysteine is a mucolytic that acts on respiratory secretions to improve clearance.

- Respiratory conditions with thick mucus: enhances clearance of secretions, easing breathing. - Acetaminophen overdose: replenishes glutathione, helping protect the liver from toxic metabolites. - Sinusitis: reduces mucus viscosity in the nasal passages, facilitating drainage.

Acetylcysteine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis following administration. - Unpleasant taste: metallic or sulfurous sensation in the mouth. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Stevens‑Johnson syndrome: rare skin blistering and detachment. - Bronchospasm: sudden narrowing of airways, especially in asthmatic patients. - Hepatic dysfunction: elevated liver enzymes or jaundice.

When using acetylcysteine, several safety considerations should be observed.

- Assess renal function: dose may need adjustment in severe impairment. - Monitor for allergic reactions: discontinue if signs of anaphylaxis appear. - Use cautiously in asthma: may precipitate bronchospasm. - Avoid concurrent high‑dose nitroglycerin: risk of profound hypotension. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Acetylcysteine can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Nitroglycerin: combined use may cause severe hypotension. - Activated charcoal: reduces acetylcysteine absorption if given simultaneously. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Carbapenem antibiotics (e.g., imipenem): may diminish mucolytic activity. - Bronchodilators: additive risk of bronchospasm in sensitive individuals. - Other mucolytics: concurrent use can increase mucus thinning beyond intended levels.